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ABSTRACT
Asthma is a heterogeneous disease comprising a
number of subtypes which may be caused by
different pathophysiologic mechanisms
(sometimes referred to as endotypes) but may
share similar observed characteristics
(phenotypes). The use of unsupervised
clustering in adult and paediatric populations
has identified subtypes of asthma based on
observable characteristics such as symptoms,
lung function, atopy, eosinophilia, obesity, and
age of onset. Here we describe different
clustering methods and demonstrate their
contributions to our understanding of the
spectrum of asthma syndrome. Precise
identification of asthma subtypes and their
pathophysiological mechanisms may lead to
stratification of patients, thus enabling more
precise therapeutic and prevention approaches.
Keywords: Adult asthma; Asthma; Clustering;
Endotypes; Paediatric asthma; Phenotypes
INTRODUCTION
Asthma is a heterogeneous disease, defined by
the most recent Global Initiative for Asthma
(GINA) global strategy for asthma management
and prevention consensus as a condition
characterised by the presence of respiratory
symptoms such as wheeze, shortness of breath,
chest tightness and cough that vary over time
and in intensity, together with variable airflow
obstruction [1]. However, various definitions of
asthma do not capture the heterogeneity of this
common complex condition. It is becoming
increasingly clear that asthma is not a single
disease, but a syndrome which consists of a
number of disease subtypes with similar
observable clinical characteristics [2]. These
observable characteristics of the disease are
often referred to as asthma phenotypes. The
term ’asthma endotype’ is not synonymous
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with phenotype, and it should be used to refer
to the distinct disease entity under the umbrella
diagnosis of asthma, which has defined
pathophysiological mechanisms that give rise
to clinical symptoms [3]. It should be
emphasised that the same observable
characteristic (i.e. phenotype) can arise as a
consequence of different underlying
pathologies (i.e. endotypes), which is
consistent with observations showing that
there are subtypes of asthma that share similar
clinical symptoms but have differing
underlying pathophysiological mechanisms
[4]. There are numerous examples in other
disease areas of a similar or identical clinical
presentation arising as a consequence of
different pathology (e.g. fever in childhood
can be caused by numerous different
mechanisms).
The traditional constructs of ‘asthma
phenotypes’ have been largely descriptive,
with little uniformity, and usually informed by
subjective observations of single dimensions of
the disease, such as triggering factors (e.g.
extrinsic and intrinsic asthma [5],
exercise-induced asthma [6]), patterns of
airway obstruction (e.g. reversible and
irreversible asthma [7]), or pathology (e.g.
eosinophilic and non-eosinophilic asthma [8]).
In paediatric asthma, changes over time in
symptoms such as wheeze have been used to
define phenotypes of wheezing illness during
childhood [9]. For example, based on clinical
observation of changes in the temporal pattern
of wheezing illness during childhood, as
confirmed in the birth cohort study (Tucson
Children’s Respiratory Study), Martinez et al.
divided children into three groups (or
phenotypes) of wheezing: transient early
wheezers, late-onset wheezers, and persistent
wheezers [10]. Although these phenotypes are
clinically meaningful in their association with
lung function and subsequent development of
asthma [11], their distinct underlying
pathophysiological mechanisms have not been
elucidated or confirmed—they cannot be
considered as endotypes.
Based on expert opinion and consensus,
Lotvall et al. [4] suggested the existence of six
asthma endotypes: aspirin-sensitive asthma,
allergic bronchopulmonary mycosis, allergic
asthma, asthma predictive index-positive
preschool wheezers, severe late-onset
hypereosinophilic asthma, and asthma in
cross-country skiers. However, the well-defined
pathophysiological mechanisms and
biomarkers which differentiate these proposed
endotypes have not been discovered, and there
is no universal agreement that these subtypes of
asthma represent true endotypes [12]. At this
time, the endotype concept remains largely
hypothetical, but may have a tangible value in
helping us to formulate strategies to better
understand the mechanisms underlying
different asthma-related diseases, and thus to
identify more effective stratified treatment
strategies [13].
In recent years, approaches to subtyping
asthma have evolved from subjective expert
opinion to more data-driven methodologies
such as machine learning [14, 15]. Statistical
machine-learning methods facilitate the
efficient exploration of data for the
identification and analysis of disease patterns.
These methods are able to draw upon the vast
array of data generated from birth and patient
cohorts in order to cluster, classify, regress, and
make predictions from data based on inherent
patterns within the large complex data set. This
is in contrast to the traditional methods based
on human observation and testing of
hypotheses using prior knowledge. Within the
context of asthma subtyping, methods such as
unsupervised clustering approaches, factor
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analysis, and principal component analysis
come into wide use within the last decade.
These are hypothesis-generating, with the
overarching notion that the inherent patterns
within the data may be a reflection of different
underlying aetiologies, genetic basis, and/or
immunopathophysiologies, and that identified
clusters may represent distinct asthma
endotypes. If this assumption is correct,
clustering methodologies could facilitate better
understanding of the disease mechanisms,
identification of novel therapeutic targets, and
better clinical trial design incorporating
group-specific targeted treatment, all of which
are essential steps towards delivery of stratified
medicine in asthma.
Here we present a review of the different
clustering methodologies—model-free and
model-based—and their applications in asthma
subtyping. We provide an overview of the major
studies and discuss the implications and
approaches used.
WHAT IS CLUSTERING?
Cluster analysis is a popular unsupervised
machine-learning method that seeks to
identify similar characteristics in subjects (or
variables) and to group them together on that
basis. In selecting groups, the primary aim is to
minimize intra-group variance while
simultaneously maximizing inter-group
variance. Clustering ‘classifies’ data by
labelling objects with cluster ‘labels’ or giving
each object a probability of belonging to a
certain cluster. Cluster labels are not known a
priori, and are derived solely from the data. This
is in contrast to supervised methods such as
logistic regression and support vector machines,
which seek to derive rules for classifying new
objects based on a set of previously classified
objects.
SELECTION OF VARIABLES/
FEATURES AND DIMENSION
REDUCTION
Cluster analysis lacks the ability to differentiate
between clinically relevant and irrelevant
variables; thus the choice of variables to input
into the clustering algorithm is one of the most
important considerations. Variable or feature
selection can be performed subjectively or
objectively. Subjective methods involve
choosing relevant variables based on expert
advice and published work. In contrast,
objective methods use data-driven approaches
to variable/feature selection, the most common
of which are stepwise methods (such as
backward and forward selection) and
dimension reduction techniques (such as
principal components analysis [PCA] and
factor analysis [FA]). Forward selection
progressively adds variables of greatest
significance (based on pre-set p values) to the
model. Backward selection starts with all
variables and progressively drops the least
significant ones until all the remaining
variables are statistically significant.
To reduce the large number of variables, the
majority of studies we reviewed employed
manual extraction based on expert advice. For
example, Moore et al. [16] manually reduced
the number of variables from 600 to 34 by
excluding variables with missing data and those
that were either deemed redundant because
information was captured by another variable
(multicollinearity) or considered not clinically
relevant. Other studies used dimension
reduction techniques such as PCA and FA,
which reduce data by generating small subsets
of generally uncorrelated variables from a large
data set of potentially correlated variables. It is
useful when we assume that there are
underlying latent (unobserved) constructs
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(factors/components) in the data which cannot
be measured directly but which can influence
responses on measured variables. Although
these two methods were used almost
interchangeably in the literature we reviewed,
there are differences between them. As a general
rule, PCA is used to reduce data into smaller
subsets, while FA is used to determine the
unobserved factors which explain the data.
CLUSTERING METHODS
Three main clustering methods have generally
been used in asthma subtyping: hierarchical
approaches, non-hierarchical or
partitioning-based approaches, and
model-based or probabilistic approaches.
Hierarchical Clustering
Hierarchical clustering aims to create a
pyramidal or (as its name implies)
‘hierarchical’ grouping of homogeneous
clusters that can be displayed in a tree-like
graph (dendrogram). It does not require the
number of clusters to be specified a priori, and
cluster assignment is based on similarity of
measured characteristics. Within hierarchical
clustering there are two subcategories:
agglomerative and divisive methods (Fig. 1).
Agglomerative Method
The agglomerative method is a bottom-up
approach that starts with each data point
assigned to its own cluster, and iteratively
merges the two closest clusters until all the
data belong to a single cluster [17]. Once
clusters are formed, there is no inter-cluster
switching. The choice of which clusters to
combine is determined by measuring
distances, similarities/dissimilarities, and/or
using linkage criteria.
This method formulates decisions based on
the pattern of variables used, without
accounting for the overall distribution.
Divisive Method
This variant is a top-down approach whereby all
objects initially belong to one cluster, which is
then recursively divided into sub-clusters until
Fig. 1 Overview of the difference between agglomerative and divisive hierarchical clustering
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thedesirednumberof clusters is obtained [18]. By
initially having a single cluster, the model gains
insight into the spread and type of data, and
subsequently makes decisions on when and how
to divide the sub-clusters.
Similarity/Dissimilarity Measures
To determine whether objects within the same
clustered group are similar or dissimilar,
distance measures and linkage criteria (Table 1)
are used. Distance metrics measure the distance
between observations, while linkage criteria
measure the distance between clusters. In
order to define a similarity measure, the actual
similarities between objects can be evaluated
using a distance measure. Choosing a measure
for calculating the distance between data can
sometimes be arbitrary, as there are no general
theoretical guidelines. The Euclidean distance
measure, which is the default method in most
statistical packages, was used in all but one of
the studies reviewed here [19].
Non-Hierarchical Clustering
The prototype of non-hierarchical clustering is
k-means (Fig. 2), which is a partitioning method
in which the number of clusters is specified a
priori and the optimal solution is chosen. It is a
variance-minimizing algorithm whereby each
subject is assigned to its nearest cluster based on
the minimum squared Euclidean distance. This
method is sensitive to outliers and is generally
limited to numeric attributes.
Model-Based Clustering
Model-based clustering (also known as latent
class analysis or mixture modelling), is based on
the assumption that the observed data are
generated by a collection of models, with each
cluster corresponding to a different model. Each
resulting cluster is represented by a (most
commonly) parametric distribution, and can
be either spherical or ellipsoidal of varying sizes
and variance. The advantage of model-based
clustering is that it can produce probabilistic
cluster assignments for individuals—i.e. it
captures the uncertainty in assigning
individuals to clusters. Bayesian extensions
(e.g. Markov chain Monte Carlo [MCMC],
expectation-maximisation [EM]) of
model-based clustering can also be used to
incorporate prior distributions to reflect
uncertainty around model assumptions.
A major challenge in model-based clustering
is identifying and representing the underlying
model assumptions with reasonable
complexity. However, unlike a model-free
approach, log-likelihood-based statistics such
as the Bayesian information criteria (BIC) and
model evidence allow us to select the most
parsimonious set of assumptions by penalising
model complexity for accuracy. This is in
contrast to model-free clustering, where an
arbitrary distance measure is used to find
clusters. Importantly, choosing the best
statistically fitting model is not enough; there
must be an element of expert input into
choosing the number of clusters to maximise
the potential clinical relevance of the identified
subgroups.
Table 1 Most commonly used linkage criteria
Linkage criteria
Centroid Measures distance between the central
points of each cluster
Ward’s
method
Measures the distance between clusters as
the ANOVA sum of squares—i.e.
combining information over all cluster
members
Complete Measures the distance between the members
of clusters farthest apart
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STABILITY OF RESULTING CLUSTERS
Cluster stability is an important aspect of
validity, because cluster methods can
generate groups in fairly homogenous data
sets. Furthermore, there is always a risk of
identifying less meaningful clusters. Stability
in this context refers to clusters not
disappearing when, for example, outliers are
added, data is sub-set, or random error is
introduced to every point to simulate
measurement error [21]. The most common
means of doing this is to apply the same
cluster method to a sample data set taken
from the original one (also termed
bootstrapping), and identifying similar
clusters using similarity measures. The
similarity values are then compared, and
stability is taken to be the mean similarity in
the new data set [21].
CLUSTERING METHODS
IN ASTHMA SUBTYPING
The Use of Principal Components
Analysis/Factor Analysis in Asthma
Subtyping
Studies which used PCA/FA as stand-alone
analyses for demonstrating the heterogeneity
of asthma syndrome and its risk factors are
summarised in Table 2 [22–40]. Sample sizes
ranged from 69 to 16,635, and the number of
variables used initially ranged from 5 to 97. The
number of resulting components/factors ranged
from one to six.
The PCA was first used in the context of
asthma by Smith et al. to examine whether
syndromes of coexisting respiratory symptoms
could be discovered using the response to a
large number of questions ([100) from
Fig. 2 A silhouette plot used for non-hierarchical cluster-
ing (k-means) (from [20], with permission). A silhouette
plot shows how close observations from neighbouring
clusters are to each other using a measure of -1 to ?1. A
value of ?1 indicates that observations are far away, 0
indicates that the observations are very close to the
boundary of deciding exactly which cluster they belong to,
and -1 indicates that the observations may be assigned to
the wrong cluster
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validated questionnaires administered in a birth
cohort (Manchester Asthma and Allergy Study
[MAAS]) [22]. The analysis demonstrated that
symptom components (wheeze, cough, wheeze
with allergens, wheeze with irritants, chest
congestion) were better indicators of the
presence and developmental changes in
observable secondary asthma phenotypes
(such as lung function, airway reactivity, and
immunoglobulin E (IgE)-mediated
sensitisation) than the presence of individual
symptoms such as wheeze.
Using factor analysis, Bailey et al. [32] found
that the intensity of asthma symptoms, asthma
management, and airflow impairment (forced
expiratory volume [FEV1]) were independent
components of the disease. This was also seen in
the study by Grazzini et al. [36], where lung
function (FEV1) was a factor independent from
asthma symptoms in a mixed teenager-adult
population of 69 asthmatics. Lung function was
also independent of inflammatory markers
(fraction of exhaled nitric oxide [FeNO], sputum
eosinophils) in other studies [33, 39, 40]. The
study by Juniper et al. [37], which included 763
patients older than 12 years who participated in
clinical trials, showed that, despite medication,
daytime and nighttime symptoms were distinct
and independent factors of asthma. Clemmer
et al. [31] used PCA to demonstrate that a clinical
‘endophenotype’ relating to corticosteroid
responsiveness best predicted corticosteroid
response in all replication populations. Other
studies in Brazilian [26], British [28], and Japanese
[41] children have shown that ‘Western diets’
were independently associated with an increased
risk of wheezing by school age.
More recently, both PCA and FA have been
used as dimension reduction techniques to
generate small subsets from a large number of
variables; these small subsets
(components/factors) were then used for further
clustering. For example, Just et al. used PCA to
reduce 40 variables to 19, characterising age and
body mass index (BMI), asthma duration,
medication use, hospitalisation, atopy, and lung
function [42], which were then used in
hierarchical clustering. This approach acts as
feature extraction in that it can initially
visualize/reveal clusters prior to the cluster
analysis.
Asthma Subtype Classification
with Model-Free Approaches
The studies identified from our literature search
which used model-free approaches for subtyping
asthma are shown in Table 3 [16, 19, 43–61]. Of 22
studies, 12 were carried out in adult populations.
Population sample sizes ranged from 57 to 1843.
The approach of choice was Ward’s hierarchical
method with some form of data reduction,
whether with PCA, multiple regression analysis,
discriminant analysis, factor analysis, or decision
trees. k-means clustering was performed in 9 of 22
studies, but always as a supplementary method.
The resultingnumbers of clusters ranged from two
to six.
Paediatric Studies
The Trousseau Asthma Program (TAP) in France
used Ward’s hierarchical clustering as the
method of choice [42, 50, 53]. In the TAP
preschool population of 551 wheezers, ‘three
clusters of wheezing’ were identified: mild
episodic viral wheeze, atopic multiple-trigger
wheeze, and non-atopic uncontrolled wheeze
[50]. The mild episodic viral wheeze class was
identified in one British [62] and one French
cohort [63] using model-based approaches (see
below), and the non-atopic uncontrolledwheeze
cluster was reproduced in a separate TAP cohort
[53]. The multiple-trigger wheeze was previously
identified using supervised methods in the Avon
Pulm Ther (2016) 2:19–41 25
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Longitudinal Study of Parents and Children
(ALSPAC) [64]. This cluster described children
with either early- or late-onset persistent
wheezing characterised by atopy and poor lung
function. A similar description of wheezing was
used in the MAAS cohort to demonstrate that
persistent wheezing and multiple early atopy
were associated with diminished lung function
by age 11 years [65].
The clusters of wheezing described in the
TAP cohort remained stable at age 5 years [53].
However, at school age, the clusters were
different: ‘asthma with severe exacerbations
and multiple allergies’, ‘severe asthma with
bronchial obstruction’, and ‘mild asthma’ [42].
These accounted for two ‘phenotypes’: asthma
with severe exacerbations, and multiple allergic
severe asthma with bronchial obstruction [42].
It is important to note, however, that not only
were the children from a separate cohort within
the TAP, but the clustering methodology was
also different; PCA was used for data reduction
and a two-step clustering approach including
k-means [42]. Furthermore, differing post hoc
analyses were used.
The Severe Asthma Research Program (SARP)
is a US multi-centre study comprising both
children and adults with persistent asthma. The
study by Fitzpatrick et al. [46] included 161
children aged 6–17 years. Variables were
selected subjectively with no data reduction
technique, and the authors derived ‘composite
variables’ from binary and questionnaire data
discerned by physicians. After Ward’s
hierarchical clustering, four clusters were
identified: ‘late-onset symptomatic asthma’,
‘early-onset atopic asthma and normal lung
function’, ‘early-onset atopic asthma with mild
airflow limitation and comorbidities’, and
‘early-onset atopic asthma with advanced
airflow limitation’. These results and the
accompanying clinical characteristics exhibitedT
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by the children were consistent with previously
reported data from clinical observations
[66–68]. However, these results differed from
findings in a Turkish cohort of children aged
6–18 years with moderate–severe asthma [19].
In contrast to previous studies, the predictive
ability of clusters and of original variables in
relation to asthma severity in this population
was relatively poor [19]. The authors concluded
that the search for asthma subtypes needs
careful selection of variables, which should be
consistent across studies, and that a cautious
interpretation of results is warranted [19].
Studies in Adults
The initial work that sparked further interest in
clustering methodology was the study
conducted by Haldar et al. in Leicester, UK
[43]. A two-step Ward’s hierarchical and
subsequent k-means cluster analysis was
performed in three different data sets
(refractory asthmatics from secondary care,
primary care data, refractory asthmatics from
clinical trial). After variable selection to identify
‘most clinically relevant’, PCA was performed,
which reduced the variables into five
components. Results of the subsequent cluster
analysis revealed three clusters in the primary
care data set and four clusters in the secondary
care data. Two clusters were identified in each
data set: ‘early-onset atopic asthma’ and ‘obese
female with no eosinophilic inflammation’. The
primary care data set identified a third ‘benign
asthma’ cluster, while the secondary care set
identified an ‘early-onset,
symptom-predominant group with minimal
eosinophils’ cluster as well as a ‘late-onset,
male predominant, eosinophilic inflammation
with few symptoms’ cluster. These results were
then validated in the clinical trial data set,
which revealed a three-cluster model similar to
that in the secondary care set.
Expanding on Haldar’s findings, the SARP
study [16], which included 726 patients older
than 12 years, began with 628 variables, which
were reduced to 34 by excluding missing data,
text data, and redundant and ‘irrelevant’
variables. Half of the variables were
composite. Ward’s method and post hoc
discriminant analysis for tree analysis was
performed to describe five clusters highly
determined by frequency of symptoms,
medication use, and lung function. Both
studies identified a group of obese women
with adult-onset asthma and less atopy, as well
as a group of severe late-onset atopic
asthmatics with poor lung function. However,
SARP did not use sputum eosinophilia, which
was an important feature in the Leicester
study. A few years later, the SARP group used
a different approach, and identified six clusters
[60]. k-means clustering partitioned the 378
subjects, while Ward’s method clustered the
112 variables into 10 InfoGain (information
gain—measures how well variables predict
clusters)-ranked variable clusters based on
symptoms, atopy, medication use, lung
function, corticosteroid use and cause, Th2
inflammation, inflammatory markers, and
demographics. Preprocessing of the data
included imputing variables with less than
5% missing data while excluding those with
more than 5%. Markov blanket algorithms
identified redundant variables. Three clusters
overlapped with previous results (severe
asthmatics, female late-onset with normal
lung function), while two were novel
(late-onset severe eosinophilic asthmatics with
nasal polyps, severe atopic Hispanics). It is
interesting to note that similar clusters were
seen in children from SARP and the Asthma
Severity Modifying Polymorphisms (AsthMaP)
Project [45], though the degree of lung
function impairment was less.
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Patrawalla et al. [49] based their clustering
and variable selection technique on SARP, and
identified clusters similar to those found by Wu
et al. [60], though the Hispanic women had
milder disease. This was explained by the fact
that the sample was from an urban New York
City population with a higher proportion of
Hispanics.
The results obtained in the Leicester and
SARP populations were reproduced in part in a
Dutch cohort of patients with severe asthma
that included more thorough inflammatory
markers [58]. The resulting three clusters
confirmed the existence of two previously
reported clusters: ‘severe eosinophilic
inflammation-predominant asthma with few
symptoms and poor lung function’, and ‘obese
late-onset asthma with low eosinophils
additionally provoked by comorbidities such
as gastrointestinal oesophageal reflux disease
(GORD)’. The third cluster in the Dutch cohort
(‘mild adult-onset well-controlled asthma’),
which was not found in Leicester or SARP, had
been seen in studies in Asian populations which
included smoking status in their analysis
[54, 55].
The recurring obesity-related subtypes were
explored in more detail in two US trials
comprising 250 adults [52]. With the
incorporation of detailed data on
inflammation, major differences were found
between the obese and non-obese populations.
Non-obese asthmatics had significantly better
lung function. Obese patients with early-onset
asthma and poor lung function had greater
degrees of systemic inflammation (represented
by the inverse association between hsCRP and
GCRa); this was directly associated with
increased glucocorticoid resistance (measured
by reduced MKP-1 expression via
dexamethasone).
Asthma Subtyping and Model-Based
Approaches
Latent Variable Modelling
This topic was recently discussed in detail in
another review article, which identified a total of
36 studies within the last 5 years that used
model-based approaches to asthma subtyping
(four in adult populations, 32 in children) [69].
Sample sizes in these studies ranged from 201 to
11,632.Methods included latent class analysis (14
studies), longitudinal latent class analysis (11
studies), latent class growth analysis (one study),
latent growth mixture modelling (eight studies),
andmixturemodels (two studies). The number of
resulting classes ranged from three to eight, and
were in most cases characterised by
physician-diagnosed asthma, atopy, and/or
FeNO. The most common outcome was ‘wheeze
phenotype’ [64, 71–82], followed by ‘atopy class’
[64, 76, 81–86].
In these studies, the wheeze classes (often
referred to as ‘phenotypes’, although by
definition these were not observable, but
latent) were described as either early-onset
(transient [78, 87, 88] or prolonged [70]),
late-onset (characterised as wheeze after age 3
years, persisting into later childhood)
[70, 74, 78, 80, 83], or persistent (controlled
and troublesome, characterised by diminished
lung function by school age) [9, 74]. Early-onset
wheeze was found to be predictive of poor lung
function, but not atopy, eczema, or rhinitis at
age 6–8 years [87]. Late-onset wheeze was
associated with bronchial hyperresponsiveness
and, in some cohorts, poorer lung function at
age 6 years [64]. The persistent wheeze
phenotype was consistently characterized by
diminished lung function by school age [9, 74].
Atopic sensitisation was the second most
common phenotype investigated by latent
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variable modelling, based on the hypothesis
that distinct subtypes may be present. Simpson
et al. applied a hidden Markov chain model to
cluster children in MAAS into five sensitization
classes using skin tests and specific IgE data at
ages 1, 3, 5, and 8 years [83]. The underlying
assumption was that children in each class had
the same probability of becoming sensitized or
resolving sensitization at each age (and to a
similar panel of inhalant and food allergens),
and that this differed between classes. Children
in one of the four classes (comprising *25% of
sensitised participants), which the authors
assigned as ‘multiple early atopy’, were much
more likely to have asthma and worse lung
function than children in any of the other
classes [65, 83]. An almost-identical five-class
model was identified by extending the analysis
in MAAS through to age 11 years and, in
another British birth cohort (Isle of Wight
study), indicating stability over time and
across different populations [84, 89]. However,
these classes of sensitisation can be identified
only by using statistical inference on
longitudinal data, and differentiation between
classes at any single cross-sectional point is
currently not possible. This underscores the
need to develop diagnostic tools that delineate
different classes at any cross-sectional time
point among the patient population, in order
to facilitate the application of these findings in
clinical practice [89–92].
In the adult population, Newby et al.
performed a cluster analysis using mixture
models on a multi-centre longitudinal
observational study of 349 asthma patients in
the British Thoracic Society Severe Refractory
Asthma Registry [93]. Variables were initially
restricted to those with less than 30% missing
data that were non-categorical, and factor
analysis was then applied. The resulting five
factors (airflow obstruction, exacerbation
frequency, IgE/BMI, treatment scaling, blood
eosinophilia) were used in the cluster analysis to
describe five clusters: (1) ‘early-onset atopic’, (2)
‘obese, late-onset’, (3) ‘normal lung function
least severe asthma’, (4) ‘late-onset,
eosinophilic’, and (5) ‘airflow obstruction’. The
best-fitting models were chosen by the Akaike
information criterion (AIC) or BIC, and the
clusters were validated using a classifier on a
separate data set from the same registry. Cluster
stability for the whole group was only 52%,
with cluster 2 accounting for 71% as the
highest, while cluster 4 accounted for only
25%. A significant proportion of subjects in
clusters 1, 4, and 5 moved to clusters 2 and 3 at
follow-up, indicating greater obesity, lower
blood eosinophilia, better lung function, and
fewer exacerbations. Taking into account small
differences in variables used, the results were
broadly in accordance with previously reported
clusters derived using model-free approaches
[16, 43]. Gaussian mixture model clustering was
also used to investigate cytokine response
patterns of peripheral blood mononuclear cells
to mite allergens, with results suggesting that
asthma was associated with a broad range of
immunophenotypes [94]. Various
machine-learning approaches were also used
to identify patterns of IgE responses to a large
number of individual allergen molecules in
component-resolved diagnostics microarrays
and to associate these with asthma and allergic
diseases [14].
CHALLENGES IN ASTHMA
CLUSTERING
Mixed Types of Data
Medicine generates many different types of
data, including binary, numerical, and
categorical variables, non-normal
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distributions, missing values, and outliers, and
applying a model that combines these is
challenging. One solution may be to
transform the raw variables into a single type
(i.e. all binary variables). Prosperi et al. [19]
showed that, although results were vastly
different when comparing the raw and binary
variables, they were still clinically consistent
with each other. However, in certain instances,
changing continuous variables into binary
variables would require the creation of
categories. For example, if we take FEV1 and
categorise it based on levels of obstruction
(e.g. 80%, 60–80%, below 60%, above 80%),
we assume that an FEV1 of 60% has the same
clinical significance as an FEV1 of 79%, which
is not necessarily true. Other issues with
dichotomizing variables include a loss of
information, leading to a reduction in
statistical power, a loss of linear relationships
between two groups, and underestimation of
outcome variability between groups [95].
Another way to minimize this problem is to
create clinically meaningful categories, but
this will likely introduce an element of
subjectivity.
Lack of Robustness to Choice of Variables
and Clustering Methods
Different input parameters, even within the
same data set, may produce different results. For
example, in the SARP, the same hierarchical
clustering techniques on the same data set
produced different clusters [16, 46]. The major
differences were in the preprocessing of the data
and the cluster input. Wu et al. also included
inflammatory markers in their analysis, which
would account for better atopy delineation [60].
As mentioned previously, the choice of
variables has been generally limited to
consideration of expert opinion based on
previous work. Furthermore, there is a
practical consideration involved in that the
variables chosen must correspond to the type
of data in the cohort, given that some studies
included all variables [58, 60, 61] in the data set,
while others chose those that were ‘most
relevant’ [42, 43, 48, 54, 55, 57]. This resulted
in patient exclusion, particularly when there
was a requirement to remove variables with
missing data. Although some studies
implemented imputation techniques in order
to overcome this [60, 93], the impact on clinical
outcome was not fully explored, which should
be taken into account when interpreting the
results.
In most studies, the choice of distance
measure was not specified, and so it was
assumed that the default measures in
statistical packages were used (i.e. Euclidean
distance). Only two studies [19, 44] specified
varying the distance measures (Gower and/or
Jaccard) to observe the effect. One study group
used centroid linkage as their similarity
measure, whereas the rest were based on
Ward. Consequently, we cannot say whether
the methods employed were the most reliable,
as there is a repository containing hundreds of
options.
Prosperi et al. hypothesized that clusters
resulting from various studies differed because
of variation in investigator choice of factors,
encoding/categorization/transformation of
variables, and methodology [19]. They
proceeded to verify this using different
hierarchical clustering and data reduction
approaches on a cohort of children aged 6–18
years from the Paediatric Asthma Clinic in
Ankara, Turkey. Data reduction was performed
by both FA and PCA, resulting in five
‘dimensions’ of variables accounting for 35%
of the variance. Multiple hierarchical clustering
analyses were performed by varying the variable
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encoding scheme, distance linkages, feature
selection, and dimensionality reduction space.
Although the authors demonstrated that small
variations in linkage-distance functions did not
affect the resulting clusters [19], they tested
only two, and it is possible that other linkage
criteria may have influenced the results. Most
significant was the fact that changes in variable
encoding schemes and transformations resulted
in different clusters [19]. While it is possible to
test the strength of the methods employed by
bootstrapping and/or multiple repetitions, this
does not necessarily translate into more
plausible results overall.
This is where model-free clustering runs into
issues, and where a model-based approach
might provide more structured methods, as
MCMC and EM algorithms are applicable to
all modelled distributions. However, in latent
class analysis, there is no agreement on the
optimal way to determine the number of
classes. The most common method is the BIC,
though other methods such as the AIC,
likelihood tests, bootstrapping, and entropy
have been used extensively, which may
account for the different classes across
populations.
Differing Subtypes Across Populations
It is clear that different clusters are identified
across different populations (see Table 3). Other
than differences in statistical methodologies,
these disparities may be due to differences in
features/variables selected to inform the mode
(for example, the choice of lung function
variables differed among studies, and
post-bronchodilator FEV1 was included in only
a few of these [43]). Of note, in addition to
influencing heterogeneity in identified clusters,
the non-inclusion of some of the potentially
important variables (e.g. post-bronchodilatorT
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lung function) may result in failure to capture
some important underlying mechanisms.
Additionally, most studies were conducted in
patients with severe or moderate–severe
asthma, and the same subtypes may not be
seen in the mild asthma population (Table 3).
It is also important to note that clusters
identified cross-sectionally at a specific time
point may not always be seen at different time
points. Further longitudinal analysis is required
to visualize how the clusters vary over time.
CONCLUSION
Our understanding of asthma has come a long
way, and data-driven hypothesis-generating
clustering methods have aided in identifying
distinct subtypes. However, we must exercise
caution when translating these results into
clinical practice, as statistical inference on a
large data set is needed to identify disease
subtypes, and biomarkers that would allow
differentiation of such subtypes at any
cross-sectional time point are in most cases
not available. Further challenges to the optimal
use of clustering methodologies include
tailoring models to individual data sets and
incorporating genetic, epigenetic, and more
detailed molecular-level data. The resulting
models should then be able to accommodate
large volumes of data in order to discern the
developmental profiles of each individual,
facilitating a genuinely personalised approach
to asthma management.
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